BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 391430)

  • 1. Evaluation of combined therapy in carcinoma of the bladder.
    Kagan AR; Gilbert HA
    Cancer Clin Trials; 1978; 1(4):305-6. PubMed ID: 391430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
    Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
    Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1).
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy of bladder cancer.
    Freiha FS; Torti FM
    Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conservative treatment of superficial transitional cell carcinoma of the bladder].
    Gruenwald I; Stein A; Lurie A
    Harefuah; 1995 Jan; 128(2):104-11. PubMed ID: 7721171
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytokine therapy of superficial bladder carcinoma. Mechanisms of action and results of therapy].
    Otto T; Kälble T
    Urologe A; 1994 Nov; 33(6):540-6. PubMed ID: 7817454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin hypogastric artery infusion combined with hyperthermia therapy for transitional cell carcinoma of the bladder.
    Jacobs SC; Maddison FE; Lawson RK
    Cancer Treat Rep; 1981; 65(9-10):891-3. PubMed ID: 7273025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What place can chemotherapy occupy in the treatment of infiltrating transitional carcinoma of the bladder?].
    Escudero Barrilero A; Jiménez Cidre M; Gutiérrez Sanz-Gadea C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T; Allona Almagro A
    Arch Esp Urol; 1986; 39(9):617-27. PubMed ID: 3827327
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined radiosurgical treatment of bladder carcinoma: preliminary results of a prospective trial.
    Salvi G; Balducci M; Cellini N; D'Andrea P; De Santis M; Valentini V; Romanini A
    Rays; 1985; 10(3):133-9. PubMed ID: 3843662
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG in carcinoma in situ and superficial bladder tumors.
    Lamm DL
    Prog Clin Biol Res; 1988; 269():497-510. PubMed ID: 3293069
    [No Abstract]   [Full Text] [Related]  

  • 12. Early stage bladder cancer.
    Messing EM
    Wis Med J; 1987 Feb; 86(2):14-7. PubMed ID: 3564513
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers.
    Kaplan RS; Cheson BD; Nelson AP
    Oncology (Williston Park); 1997 Sep; 11(9):1348, 1351. PubMed ID: 9306423
    [No Abstract]   [Full Text] [Related]  

  • 14. BCG for bladder cancer.
    Med Lett Drugs Ther; 1991 Apr; 33(841):29-30. PubMed ID: 2002783
    [No Abstract]   [Full Text] [Related]  

  • 15. A case report of multimodality therapy of bladder cancer.
    Koukol SC; Lamm DL; Sosnowski JT; Shriver JS
    W V Med J; 1994 May; 90(5):193-4. PubMed ID: 8053169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of treatment of 1,475 patients with bladder carcinoma in the region of Amsterdam, The Netherlands.
    Rasker FM
    Prog Clin Biol Res; 1988; 260():347-56. PubMed ID: 3362892
    [No Abstract]   [Full Text] [Related]  

  • 18. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
    Escudero Barrilero A
    Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.